Joint Venture to Manufacture and Distribute Tenofovir Gel in Africa
June 16, 2011
CONRAD and the South African Government's Technology Innovation Agency (TIA) on Tuesday announced a license agreement that grants TIA the rights to manufacture and distribute tenofovir gel in Africa, according to a CONRAD statement. TIA also will establish a joint venture with drug maker Cipla Medpro and iThemba Pharmaceuticals for the registration, manufacturing and distribution of the gel in South Africa and other African nations (6/14). A large trial of tenofovir gel among women was also announced on Tuesday (6/15).
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)